CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 123 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,000 | +300.0% | 2,517 | +312.6% | 0.00% | – |
| Q3 2021 | $2,000 | -71.4% | 610 | -62.5% | 0.00% | – |
| Q2 2021 | $7,000 | -87.7% | 1,626 | -83.5% | 0.00% | -100.0% |
| Q4 2020 | $57,000 | +58.3% | 9,868 | -5.1% | 0.00% | -25.0% |
| Q2 2020 | $36,000 | +3500.0% | 10,402 | +1070.1% | 0.00% | – |
| Q1 2020 | $1,000 | -80.0% | 889 | -62.3% | 0.00% | -100.0% |
| Q4 2019 | $5,000 | +400.0% | 2,361 | +781.0% | 0.00% | – |
| Q3 2019 | $1,000 | -98.0% | 268 | -93.0% | 0.00% | -100.0% |
| Q2 2018 | $51,000 | – | 3,835 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |